Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Buy” by Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has earned an average recommendation of “Buy” from the sixteen research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $27.00.

PRVA has been the topic of several research analyst reports. Robert W. Baird upped their price objective on Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a research note on Tuesday. Needham & Company LLC reissued a “buy” rating and issued a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. Stephens reaffirmed an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Piper Sandler lifted their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, February 28th. Finally, Truist Financial boosted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Thursday, April 10th.

Insider Activity at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares of the company’s stock, valued at $4,021,148.88. This represents a 3.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 14.20% of the stock is owned by insiders.

Institutional Trading of Privia Health Group

A number of institutional investors have recently modified their holdings of PRVA. Quadrant Capital Group LLC raised its position in Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after purchasing an additional 511 shares during the last quarter. Park Avenue Securities LLC raised its holdings in shares of Privia Health Group by 3.8% during the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after acquiring an additional 532 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in Privia Health Group by 8.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after acquiring an additional 533 shares during the period. First Horizon Advisors Inc. boosted its holdings in Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after acquiring an additional 632 shares in the last quarter. Finally, Summit Investment Advisors Inc. raised its stake in Privia Health Group by 6.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock worth $209,000 after buying an additional 678 shares in the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $23.68 on Friday. The firm has a market cap of $2.87 billion, a price-to-earnings ratio of 236.82, a P/E/G ratio of 3.47 and a beta of 0.88. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $26.04. The firm’s 50-day simple moving average is $23.83 and its two-hundred day simple moving average is $21.63.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.